Published in Bioconjug Chem on April 18, 2012
Stimuli-responsive nanocarriers for drug delivery. Nat Mater (2013) 3.52
Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression. J Control Release (2013) 1.42
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm (2013) 0.97
The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression. Biomaterials (2012) 0.88
Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation. Mol Pharm (2014) 0.80
Acid-Sensitive Sheddable PEGylated PLGA Nanoparticles Increase the Delivery of TNF-α siRNA in Chronic Inflammation Sites. Mol Ther Nucleic Acids (2016) 0.80
Utilization of Enzyme-Immobilized Mesoporous Silica Nanocontainers (IBN-4) in Prodrug-Activated Cancer Theranostics. Nanomaterials (Basel) (2015) 0.79
Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. Mol Pharm (2014) 0.76
A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity. J Pharm Pharmacol (2012) 0.75
Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity. Int J Pharm (2017) 0.75
Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model. Mol Pharm (2017) 0.75
Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol. Int J Pharm (2017) 0.75
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res (1986) 15.83
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm (2005) 7.53
Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today (2006) 4.35
FRET or no FRET: a quantitative comparison. Biophys J (2003) 3.88
Structure and design of polymeric surfactant-based drug delivery systems. J Control Release (2001) 3.48
PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev (2003) 3.19
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther (2006) 2.48
Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc Natl Acad Sci U S A (2008) 2.16
Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release (2003) 1.93
Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir (2008) 1.88
Extracellular pH distribution in human tumours. Int J Hyperthermia (1995) 1.81
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem (2005) 1.75
Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst (2003) 1.69
Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials (2011) 1.66
Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers. J Am Chem Soc (2004) 1.58
Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release (2005) 1.52
Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv (2010) 1.51
Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release (2007) 1.45
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release (2004) 1.44
Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release (1998) 1.41
Supramolecular drug-delivery systems based on polymeric core-shell architectures. Angew Chem Int Ed Engl (2004) 1.36
Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Deliv Rev (2003) 1.22
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. Int J Pharm (2011) 1.20
Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release (2003) 1.13
Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano (2010) 1.12
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types. J Control Release (2007) 1.06
Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. Langmuir (2009) 1.06
Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin. Biomaterials (2008) 1.05
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid. J Control Release (2008) 1.02
A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res (2007) 1.01
Use of block copolymers of poly(ortho esters) and poly (ethylene glycol) micellar carriers as potential tumour targeting systems. J Drug Target (2003) 1.00
Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. Anticancer Res (2007) 0.96
Gemcitabine: a pharmacologic and clinical overview. Cancer Nurs (1999) 0.96
Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. Langmuir (2008) 0.95
Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells. BMC Cancer (2004) 0.93
Selective Protection of 2',2'-Difluorodeoxycytidine (Gemcitabine). J Org Chem (1999) 0.93
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Curr Drug Deliv (2007) 0.92
RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. J Drug Target (2009) 0.90
Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. Br J Cancer (2005) 0.90
Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells. J Control Release (2010) 0.87
The control of dendritic cell maturation by pH-sensitive polyion complex micelles. Biomaterials (2008) 0.84
A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma. Melanoma Res (2005) 0.83
PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat Commun (2010) 2.54
TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes. Cell (2012) 2.35
Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun (2012) 1.85
Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1. J Control Release (2011) 1.59
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines (2010) 1.57
Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression. J Control Release (2013) 1.42
A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev Cell (2013) 1.36
Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. J Control Release (2009) 1.20
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. Int J Pharm (2011) 1.20
Kinetics of two-electron oxidations by the compound I derivative of chloroperoxidase, a model for cytochrome P450 oxidants. Org Lett (2006) 1.18
Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel. Int J Pharm (2009) 1.06
Phosphoinositide isoforms determine compartment-specific ion channel activity. Proc Natl Acad Sci U S A (2012) 1.06
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm (2013) 0.97
Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities. Pharm Res (2006) 0.97
Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Vaccine (2006) 0.97
SLOW WALKER2, a NOC1/MAK21 homologue, is essential for coordinated cell cycle progression during female gametophyte development in Arabidopsis. Plant Physiol (2009) 0.97
Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomedicine (2011) 0.96
Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol (2006) 0.96
Few-layered CoHPO4 · 3H2O ultrathin nanosheets for high performance of electrode materials for supercapacitors. Nanoscale (2013) 0.95
Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS PharmSciTech (2003) 0.95
Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. Int J Pharm (2006) 0.94
Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles. Int J Pharm (2012) 0.93
Performance map of a cluster detection test using extended power. Int J Health Geogr (2013) 0.92
Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release (2012) 0.92
EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. J Control Release (2011) 0.90
Tumor chemo-immunotherapy using gemcitabine and a synthetic dsRNA. Cancer Biol Ther (2007) 0.89
Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain. Int J Pharm (2010) 0.88
The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression. Biomaterials (2012) 0.88
Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design. Eur J Pharm Biopharm (2010) 0.87
Correlated evolution of transcription factors and their binding sites. Bioinformatics (2011) 0.87
Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin. Mol Pharm (2014) 0.87
Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles. Pharm Res (2006) 0.86
Immunization by application of DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage. Mol Ther (2007) 0.85
Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens. Mol Pharm (2011) 0.84
CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope. J Immunother (2007) 0.84
Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks. J Pharm Sci (2002) 0.83
Desaturase reactions complicate the use of norcarane as a mechanistic probe. Unraveling the mixture of twenty-plus products formed in enzyme-catalyzed oxidations of norcarane. J Org Chem (2007) 0.82
Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. FEMS Immunol Med Microbiol (2008) 0.82
Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy. Int J Pharm (2006) 0.81
Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice. J Pharm Pharmacol (2006) 0.81
Extrasegmental analgesia of heterotopic electroacupuncture stimulation on visceral pain rats. Brain Res (2010) 0.81
Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA. Nanomedicine (Lond) (2012) 0.80
Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity. Radiother Oncol (2008) 0.80
Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation. Mol Pharm (2014) 0.80
Transcutaneous DNA immunization following waxing-based hair depilation. J Control Release (2011) 0.80
Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods (2003) 0.80
Products from enzyme-catalyzed oxidations of norcarenes. J Org Chem (2007) 0.80
Nanomedicine: the promise and challenges in cancer chemotherapy. Adv Exp Med Biol (2014) 0.79
The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin. J Pharm Pharmacol (2011) 0.79
Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells. Cancer Biol Ther (2012) 0.79
Replicase-based plasmid DNA shows anti-tumor activity. BMC Cancer (2011) 0.78
Spatial heterogeneity of type I error for local cluster detection tests. Int J Health Geogr (2014) 0.78
An empiric weight computation for record linkage using linearly combined fields' similarity scores. Conf Proc IEEE Eng Med Biol Soc (2014) 0.78
Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. Int J Pharm (2005) 0.78
Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model. Cancer Biol Ther (2013) 0.77
AppA C-terminal plays an important role in its thermostability in Escherichia coli. Curr Microbiol (2012) 0.76
Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy. Expert Rev Vaccines (2015) 0.76
Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy. Eur J Pharm Biopharm (2005) 0.76
Alkalophilic adaptation of XynB endoxylanase from Aspergillus niger via rational design of pKa of catalytic residues. J Biosci Bioeng (2013) 0.76
Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model. Mol Pharm (2013) 0.76
N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm (2009) 0.76
Transcutaneous DNA immunization following waxing-based hair depilation elicits both humoral and cellular immune responses. Eur J Pharm Biopharm (2012) 0.76
A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity. J Pharm Pharmacol (2012) 0.75
Highlights from the latest articles on vaccine development using nanoparticles. Nanomedicine (Lond) (2014) 0.75
Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis. Clin Cardiol (2014) 0.75
Skin penetration of topically applied white mustard extract and its effects on epidermal Langerhans cells and cytokines. Int J Pharm (2013) 0.75
A thermo-sensitive polymeric gel containing a gadolinium (Gd) compound encapsulated into liposomes significantly extended the retention of the Gd in tumors. Drug Dev Ind Pharm (2008) 0.75
Exact confidence intervals for the average causal effect on a binary outcome. Stat Med (2016) 0.75
Uniform M3PMo12O40·nH2O (M = NH4+, K+, Cs+) rhombic dodecahedral nanocrystals for effective antibacterial agents. Dalton Trans (2013) 0.75
Relationship between Escherichia coli AppA phytase's thermostability and salt bridges. J Biosci Bioeng (2013) 0.75
Ferric phosphate hydroxide microcrystals for highly efficient visible-light-driven photocatalysts. Chemphyschem (2013) 0.75
TPZ, a bright centrosymmetric two-photon scaffold for bioimaging. Chem Commun (Camb) (2017) 0.75
Long-term phase-locking technique for locking the repetition rate of an optical frequency comb laser with 1.67 × 10<sup>-19</sup> precision. Appl Opt (2016) 0.75